Early evaluation of a new regional pathway for tri-modality treatment in stage III-N2 NSCLC in Greater Manchester

Aparna Iyer; Fiona Blackhall; Neil Bayman; Laura Cove-Smith; Corinne Faivre-Finn; David Woolf; Louise Brown; Simon Bailey; Seamus Grundy; Duncan Fullerton; Christopher Craig; Felice Granato; Kandadai Rammohan; Jackie Fenemore; Paul Taylor; Matthew Evison

doi:10.1016/s0169-5002(22)00054-x

Early evaluation of a new regional pathway for tri-modality treatment in stage III-N2 NSCLC in Greater Manchester

Aparna Iyer, Fiona Blackhall, Neil Bayman, Laura Cove-Smith, Corinne Faivre-Finn, David Woolf, Louise Brown, Simon Bailey, Seamus Grundy, Duncan Fullerton, Christopher Craig, Felice Granato, Kandadai Rammohan, Jackie Fenemore, Paul Taylor, Matthew Evison

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S4
Journal	Lung Cancer
Volume	165
DOIs	https://doi.org/10.1016/s0169-5002(22)00054-x
Publication status	Published - Mar 2022

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/s0169-5002(22)00054-x

Cite this

Iyer, A., Blackhall, F., Bayman, N., Cove-Smith, L., Faivre-Finn, C., Woolf, D., Brown, L., Bailey, S., Grundy, S., Fullerton, D., Craig, C., Granato, F., Rammohan, K., Fenemore, J., Taylor, P., & Evison, M. (2022). Early evaluation of a new regional pathway for tri-modality treatment in stage III-N2 NSCLC in Greater Manchester. Lung Cancer, 165, S4. https://doi.org/10.1016/s0169-5002(22)00054-x

@article{70593ec46ef843889eba466839e589a1,

title = "Early evaluation of a new regional pathway for tri-modality treatment in stage III-N2 NSCLC in Greater Manchester",

author = "Aparna Iyer and Fiona Blackhall and Neil Bayman and Laura Cove-Smith and Corinne Faivre-Finn and David Woolf and Louise Brown and Simon Bailey and Seamus Grundy and Duncan Fullerton and Christopher Craig and Felice Granato and Kandadai Rammohan and Jackie Fenemore and Paul Taylor and Matthew Evison",

year = "2022",

month = mar,

doi = "10.1016/s0169-5002(22)00054-x",

language = "English",

volume = "165",

pages = "S4",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier BV",

}

Iyer, A, Blackhall, F, Bayman, N, Cove-Smith, L, Faivre-Finn, C, Woolf, D, Brown, L, Bailey, S, Grundy, S, Fullerton, D, Craig, C, Granato, F, Rammohan, K, Fenemore, J, Taylor, P & Evison, M 2022, 'Early evaluation of a new regional pathway for tri-modality treatment in stage III-N2 NSCLC in Greater Manchester', Lung Cancer, vol. 165, pp. S4. https://doi.org/10.1016/s0169-5002(22)00054-x

TY - JOUR

T1 - Early evaluation of a new regional pathway for tri-modality treatment in stage III-N2 NSCLC in Greater Manchester

AU - Iyer, Aparna

AU - Blackhall, Fiona

AU - Bayman, Neil

AU - Cove-Smith, Laura

AU - Faivre-Finn, Corinne

AU - Woolf, David

AU - Brown, Louise

AU - Bailey, Simon

AU - Grundy, Seamus

AU - Fullerton, Duncan

AU - Craig, Christopher

AU - Granato, Felice

AU - Rammohan, Kandadai

AU - Fenemore, Jackie

AU - Taylor, Paul

AU - Evison, Matthew

PY - 2022/3

Y1 - 2022/3

UR - https://www.mendeley.com/catalogue/41f370ff-919b-3b44-8d87-c2af7522c362/

U2 - 10.1016/s0169-5002(22)00054-x

DO - 10.1016/s0169-5002(22)00054-x

M3 - Article

SN - 0169-5002

VL - 165

SP - S4

JO - Lung Cancer

JF - Lung Cancer

ER -

Early evaluation of a new regional pathway for tri-modality treatment in stage III-N2 NSCLC in Greater Manchester

Research Beacons, Institutes and Platforms

UN SDGs

Access to Document

Other files and links

Cite this